ストックスクリーナーアプリを入手
9.27
15.30%
1.23
アフターアワーズ：
9.25
-0.02
-0.22%
前日終値:
$8.04
開ける：
$8.295
24時間の取引高:
8.66M
Relative Volume:
1.91
時価総額：
$1.59B
収益：
$1.84M
当期純損益:
$-118.44M
株価収益率:
-11.18
EPS:
-0.8291
ネットキャッシュフロー:
$-98.51M
1週間 パフォーマンス:
+12.50%
1か月 パフォーマンス:
+0.32%
6か月 パフォーマンス:
+205.94%
1年 パフォーマンス:
+263.53%
1日の値動き範囲:
$8.285
$9.83
1週間の範囲:
$7.79
$9.83
52週間の値動き範囲:
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
Compare ABSI vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
9.27 | 1.41B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
516.34 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
789.45 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
158.07 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
995.77 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
196.94 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | 開始されました | JP Morgan | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-01-22 | 開始されました | Needham | Buy |
| 2024-10-02 | 開始されました | Guggenheim | Buy |
| 2024-07-03 | 開始されました | Morgan Stanley | Overweight |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 開始されました | Truist | Buy |
| 2022-03-02 | 再開されました | Cowen | Market Perform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-11-10 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | BofA Securities | Neutral |
| 2021-08-16 | 開始されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | Credit Suisse | Outperform |
| 2021-08-16 | 開始されました | Stifel | Hold |
すべてを表示
Absci Corp (ABSI) 最新ニュース
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic - Yahoo Finance
Lifesci Capital Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Absci (ABSI) Institutional Ownership 2026 - MarketBeat
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $16 - moomoo.com
Absci Corporation Stock (ABSI) Opinions on Investor Conference Participation - Quiver Quantitative
Bank of New York Mellon Corp Buys Shares of 386,832 Absci Corporation $ABSI - MarketBeat
ABSI: Absci Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Absci Corporation $ABSI Shares Bought by Bank of America Corp DE - MarketBeat
Absci Corp (ABSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Absci (NASDAQ:ABSI) Stock Price Down 4.8%Should You Sell? - MarketBeat
Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential? - simplywall.st
Absci Corp CFO Zachariah Jonasson Reports RSU Tax Withholding Share Transaction - Kalkine Media
Absci to Participate in Upcoming Investor Conferences - The Manila Times
Deutsche Bank AG Acquires New Stake in Absci Corporation $ABSI - MarketBeat
Artia Global Partners LP Acquires Shares of 464,444 Absci Corporation $ABSI - marketbeat.com
Absci (NASDAQ:ABSI) Trading 8.5% HigherWhat's Next? - MarketBeat
Certain Common Stock of Absci Corporation are subject to a Lock-Up Agreement Ending on 24-AUG-2026. - marketscreener.com
Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat
Morgan Stanley Maintains Absci Corp(ABSI.US) With Hold Rating, Raises Target Price to $10 - 富途牛牛
Absci (ABSI) Q2 2026 Earnings Call Transcript - AOL.com
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does. - GlobeNewswire
Ransi Mudalinayake Somaratne Net Worth (2026) - GuruFocus
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma - The Globe and Mail
ABSI Looks 1092.2% Overvalued on GF Value™ - GuruFocus
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.4%Here's Why - MarketBeat
Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely? - Moomoo
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corp. Earnings Call Highlights ABS-201 And Cash - The Globe and Mail
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $11 to $16 - Moomoo
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation - Yahoo Finance
Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings - simplywall.st
Absci (NASDAQ:ABSI) Shares Gap Down After Earnings Miss - marketbeat.com
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
BTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? - Yahoo Finance
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - Moomoo
ABSI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Absci Q2 2026 Earnings Call Transcript - MarketBeat
Absci Q2 Loss Narrows, Revenue Declines - Moomoo
Why is Absci stock tumbling today? - Investing.com
ABSI Looks 934.1% Overvalued on GF Value™ - GuruFocus
Absci Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Absci misses Q2 2026 estimates as stock falls after hours - Investing.com Nigeria
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Absci Corp (ABSI) 財務データ
収益
当期純利益
現金流量
EPS
Absci Corp (ABSI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pangalos Menelas N | Director |
May 13 '26 |
Buy |
5.36 |
37,453 |
200,748 |
232,308 |
| Busch Andreas | Chief Innovation Officer |
Mar 12 '26 |
Buy |
2.29 |
100,000 |
229,000 |
421,446 |
| Pangalos Menelas N | Director |
Feb 27 '26 |
Buy |
2.74 |
75,095 |
205,760 |
189,055 |
| McClain Sean | Chief Executive Officer |
Feb 23 '26 |
Option Exercise |
1.21 |
396,399 |
479,643 |
8,730,966 |
| McClain Sean | Chief Executive Officer |
Feb 02 '26 |
Sale |
2.99 |
26,761 |
80,015 |
8,334,567 |
| Jonasson Zachariah | CFO / CBO |
Feb 02 '26 |
Sale |
2.99 |
17,496 |
52,313 |
383,538 |
| VAN HOUTEN FRANS | Director |
Dec 05 '25 |
Buy |
3.72 |
40,000 |
148,800 |
63,320 |
| Pangalos Menelas N | Director |
Sep 22 '25 |
Buy |
2.66 |
95,785 |
254,788 |
113,960 |
| Bedrick Todd | SVP, CAO |
Sep 22 '25 |
Buy |
2.70 |
10,000 |
27,000 |
180,428 |
0.79%
大文字化:
|
ボリューム (24 時間):